Home    Back

Bovine intestinal alkaline phosphatase (biap)    (DrugBank: Alkaline Phosphatase)

4 diseases
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis2
93Primary biliary cholangitis [Primary biliary cirrhosis (~Mar 2017)]0
97Ulcerative colitis1
172Hypophosphatasia0

46. Malignant rheumatoid arthritis    [ 4,183 clinical trials,   2,538 drugs,   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways]
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 4,183 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01416493
(ClinicalTrials.gov)		May 201111/8/2011Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid ArthritisAn OPEN LABEL Phase II Safety Study of Bovine Intestinal Alkaline Phosphatase (bIAP), an Inflammation Modulating Moiety, in RA PatientsAcute Rheumatoid ArthritisDrug: s.c. injections of bovine intestinal Alkaline PhosphataseAlloksys Life Sciences B.V.Aix ScientificsCompleted18 YearsN/ABoth6Phase 1;Phase 2United Kingdom
2EUCTR2008-007346-63-GB
(EUCTR)		05/04/201111/10/2010Reumap: An Open Label phase II study of Bovine Intestinal Alkaline Phosphatase (bIAP), An Inflammation modulating moiety, in RA patients - REUMAPReumap: An Open Label phase II study of Bovine Intestinal Alkaline Phosphatase (bIAP), An Inflammation modulating moiety, in RA patients - REUMAP Rheumatoid ArthritisProduct Name: bIAP
Product Code: EC 3.1.3.1
INN or Proposed INN: bovine intesastinal alkaline phosphatase (bIAP)
Other descriptive name: bIAP		Alloksys Life Sciences B.V.NULLNot RecruitingFemale: yes
Male: yes		Phase 2United Kingdom

93. Primary biliary cholangitis [Primary biliary cirrhosis (~Mar 2017)]    [ 230 clinical trials,   215 drugs,   (DrugBank: 51 drugs),   34 drug target genes,   107 drug target pathways]
Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 230 trial found

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00727324
(ClinicalTrials.gov)		May 200630/7/2008Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative ColitisA Pilot, Open-label, Multi-center Clinical Trial to Investigate the Safety and Efficacy of Bovine-Calf Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis.Ulcerative ColitisDrug: bovine intestinal alkaline phosphatase (BIAP)AM-PharmaCRM Biometrics GmbH;Sintesi Research Srl;Vigilex BVCompleted18 YearsN/ABoth22Phase 2Czech Republic;Italy

172. Hypophosphatasia    [ 32 clinical trials,   18 drugs,   (DrugBank: 4 drugs),   3 drug target genes,   6 drug target pathways]
Searched query = "Hypophosphatasia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 32 trial found